Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis
In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been pre...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2018-02, Vol.71 (5), p.475-485 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 485 |
---|---|
container_issue | 5 |
container_start_page | 475 |
container_title | Journal of the American College of Cardiology |
container_volume | 71 |
creator | Annabi, Mohamed-Salah Touboul, Eden Dahou, Abdellaziz Burwash, Ian G. Bergler-Klein, Jutta Enriquez-Sarano, Maurice Orwat, Stefan Baumgartner, Helmut Mascherbauer, Julia Mundigler, Gerald Cavalcante, João L. Larose, Éric Pibarot, Philippe Clavel, Marie-Annick |
description | In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated.
The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS).
One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis.
Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p < 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003).
In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028)
[Display omitted] |
doi_str_mv | 10.1016/j.jacc.2017.11.052 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1999191845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109717417785</els_id><sourcerecordid>2007528462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EokvhBTigSFw4kDBjx0kscalKW5AWcSgckeW1J62jTbzYCVXfps_SJ8PLFg4cOM1I8_2_Rh9jLxEqBGzeDdVgrK04YFshViD5I7ZCKbtSSNU-ZitohSwRVHvEnqU0AEDToXrKjriq8ypxxb5_CJtlNqOfqLicI6VUnNnrYE10PlxFs7u-LfoQ7-8-m8lc0UjTXIS-WIeb8nwbbt7-3i6icX5_OQlx9vb-7nKmKSSfnrMnvdkmevEwj9m387Ovpx_L9ZeLT6cn69LWEuZSkOlblEoAoOprJwR0ZETb8Q42Dqwja2WrONpaKOpww60yjbO8V9I0BsQxe3Po3cXwY6E069EnS9utmSgsSaNSChV2tczo63_QISxxyt9pDtBK3tUNzxQ_UDaGlCL1ehf9aOKtRtB7-XrQe_l6L18j6iw_h149VC-bkdzfyB_bGXh_ACi7-Okp6mSzN0vOR7KzdsH_r_8XnbqWZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007528462</pqid></control><display><type>article</type><title>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</title><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Annabi, Mohamed-Salah ; Touboul, Eden ; Dahou, Abdellaziz ; Burwash, Ian G. ; Bergler-Klein, Jutta ; Enriquez-Sarano, Maurice ; Orwat, Stefan ; Baumgartner, Helmut ; Mascherbauer, Julia ; Mundigler, Gerald ; Cavalcante, João L. ; Larose, Éric ; Pibarot, Philippe ; Clavel, Marie-Annick</creator><creatorcontrib>Annabi, Mohamed-Salah ; Touboul, Eden ; Dahou, Abdellaziz ; Burwash, Ian G. ; Bergler-Klein, Jutta ; Enriquez-Sarano, Maurice ; Orwat, Stefan ; Baumgartner, Helmut ; Mascherbauer, Julia ; Mundigler, Gerald ; Cavalcante, João L. ; Larose, Éric ; Pibarot, Philippe ; Clavel, Marie-Annick</creatorcontrib><description>In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated.
The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS).
One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis.
Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p < 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003).
In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028)
[Display omitted]</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2017.11.052</identifier><identifier>PMID: 29406851</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aortic stenosis ; Aortic valve ; Calcification ; Calcium ; Cardiology ; Cardiovascular disease ; Computed tomography ; Coronary vessels ; Criteria ; Echocardiography ; Electrocardiography ; Flow velocity ; Guidelines ; Heart ; Hypertension ; LV dysfunction ; Medical imaging ; Mercury ; Mortality ; Patients ; Renal failure ; Stenosis ; Stress ; stress echocardiography ; Stresses ; Stroke ; survival ; Ventricle</subject><ispartof>Journal of the American College of Cardiology, 2018-02, Vol.71 (5), p.475-485</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Feb 6, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</citedby><cites>FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2017.11.052$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29406851$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Annabi, Mohamed-Salah</creatorcontrib><creatorcontrib>Touboul, Eden</creatorcontrib><creatorcontrib>Dahou, Abdellaziz</creatorcontrib><creatorcontrib>Burwash, Ian G.</creatorcontrib><creatorcontrib>Bergler-Klein, Jutta</creatorcontrib><creatorcontrib>Enriquez-Sarano, Maurice</creatorcontrib><creatorcontrib>Orwat, Stefan</creatorcontrib><creatorcontrib>Baumgartner, Helmut</creatorcontrib><creatorcontrib>Mascherbauer, Julia</creatorcontrib><creatorcontrib>Mundigler, Gerald</creatorcontrib><creatorcontrib>Cavalcante, João L.</creatorcontrib><creatorcontrib>Larose, Éric</creatorcontrib><creatorcontrib>Pibarot, Philippe</creatorcontrib><creatorcontrib>Clavel, Marie-Annick</creatorcontrib><title>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated.
The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS).
One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis.
Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p < 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003).
In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028)
[Display omitted]</description><subject>Aortic stenosis</subject><subject>Aortic valve</subject><subject>Calcification</subject><subject>Calcium</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Computed tomography</subject><subject>Coronary vessels</subject><subject>Criteria</subject><subject>Echocardiography</subject><subject>Electrocardiography</subject><subject>Flow velocity</subject><subject>Guidelines</subject><subject>Heart</subject><subject>Hypertension</subject><subject>LV dysfunction</subject><subject>Medical imaging</subject><subject>Mercury</subject><subject>Mortality</subject><subject>Patients</subject><subject>Renal failure</subject><subject>Stenosis</subject><subject>Stress</subject><subject>stress echocardiography</subject><subject>Stresses</subject><subject>Stroke</subject><subject>survival</subject><subject>Ventricle</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi0EokvhBTigSFw4kDBjx0kscalKW5AWcSgckeW1J62jTbzYCVXfps_SJ8PLFg4cOM1I8_2_Rh9jLxEqBGzeDdVgrK04YFshViD5I7ZCKbtSSNU-ZitohSwRVHvEnqU0AEDToXrKjriq8ypxxb5_CJtlNqOfqLicI6VUnNnrYE10PlxFs7u-LfoQ7-8-m8lc0UjTXIS-WIeb8nwbbt7-3i6icX5_OQlx9vb-7nKmKSSfnrMnvdkmevEwj9m387Ovpx_L9ZeLT6cn69LWEuZSkOlblEoAoOprJwR0ZETb8Q42Dqwja2WrONpaKOpww60yjbO8V9I0BsQxe3Po3cXwY6E069EnS9utmSgsSaNSChV2tczo63_QISxxyt9pDtBK3tUNzxQ_UDaGlCL1ehf9aOKtRtB7-XrQe_l6L18j6iw_h149VC-bkdzfyB_bGXh_ACi7-Okp6mSzN0vOR7KzdsH_r_8XnbqWZA</recordid><startdate>20180206</startdate><enddate>20180206</enddate><creator>Annabi, Mohamed-Salah</creator><creator>Touboul, Eden</creator><creator>Dahou, Abdellaziz</creator><creator>Burwash, Ian G.</creator><creator>Bergler-Klein, Jutta</creator><creator>Enriquez-Sarano, Maurice</creator><creator>Orwat, Stefan</creator><creator>Baumgartner, Helmut</creator><creator>Mascherbauer, Julia</creator><creator>Mundigler, Gerald</creator><creator>Cavalcante, João L.</creator><creator>Larose, Éric</creator><creator>Pibarot, Philippe</creator><creator>Clavel, Marie-Annick</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20180206</creationdate><title>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</title><author>Annabi, Mohamed-Salah ; Touboul, Eden ; Dahou, Abdellaziz ; Burwash, Ian G. ; Bergler-Klein, Jutta ; Enriquez-Sarano, Maurice ; Orwat, Stefan ; Baumgartner, Helmut ; Mascherbauer, Julia ; Mundigler, Gerald ; Cavalcante, João L. ; Larose, Éric ; Pibarot, Philippe ; Clavel, Marie-Annick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aortic stenosis</topic><topic>Aortic valve</topic><topic>Calcification</topic><topic>Calcium</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Computed tomography</topic><topic>Coronary vessels</topic><topic>Criteria</topic><topic>Echocardiography</topic><topic>Electrocardiography</topic><topic>Flow velocity</topic><topic>Guidelines</topic><topic>Heart</topic><topic>Hypertension</topic><topic>LV dysfunction</topic><topic>Medical imaging</topic><topic>Mercury</topic><topic>Mortality</topic><topic>Patients</topic><topic>Renal failure</topic><topic>Stenosis</topic><topic>Stress</topic><topic>stress echocardiography</topic><topic>Stresses</topic><topic>Stroke</topic><topic>survival</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Annabi, Mohamed-Salah</creatorcontrib><creatorcontrib>Touboul, Eden</creatorcontrib><creatorcontrib>Dahou, Abdellaziz</creatorcontrib><creatorcontrib>Burwash, Ian G.</creatorcontrib><creatorcontrib>Bergler-Klein, Jutta</creatorcontrib><creatorcontrib>Enriquez-Sarano, Maurice</creatorcontrib><creatorcontrib>Orwat, Stefan</creatorcontrib><creatorcontrib>Baumgartner, Helmut</creatorcontrib><creatorcontrib>Mascherbauer, Julia</creatorcontrib><creatorcontrib>Mundigler, Gerald</creatorcontrib><creatorcontrib>Cavalcante, João L.</creatorcontrib><creatorcontrib>Larose, Éric</creatorcontrib><creatorcontrib>Pibarot, Philippe</creatorcontrib><creatorcontrib>Clavel, Marie-Annick</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Annabi, Mohamed-Salah</au><au>Touboul, Eden</au><au>Dahou, Abdellaziz</au><au>Burwash, Ian G.</au><au>Bergler-Klein, Jutta</au><au>Enriquez-Sarano, Maurice</au><au>Orwat, Stefan</au><au>Baumgartner, Helmut</au><au>Mascherbauer, Julia</au><au>Mundigler, Gerald</au><au>Cavalcante, João L.</au><au>Larose, Éric</au><au>Pibarot, Philippe</au><au>Clavel, Marie-Annick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2018-02-06</date><risdate>2018</risdate><volume>71</volume><issue>5</issue><spage>475</spage><epage>485</epage><pages>475-485</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated.
The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS).
One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis.
Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p < 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003).
In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028)
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29406851</pmid><doi>10.1016/j.jacc.2017.11.052</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-1097 |
ispartof | Journal of the American College of Cardiology, 2018-02, Vol.71 (5), p.475-485 |
issn | 0735-1097 1558-3597 |
language | eng |
recordid | cdi_proquest_miscellaneous_1999191845 |
source | ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Aortic stenosis Aortic valve Calcification Calcium Cardiology Cardiovascular disease Computed tomography Coronary vessels Criteria Echocardiography Electrocardiography Flow velocity Guidelines Heart Hypertension LV dysfunction Medical imaging Mercury Mortality Patients Renal failure Stenosis Stress stress echocardiography Stresses Stroke survival Ventricle |
title | Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A35%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dobutamine%20Stress%20Echocardiography%20for%C2%A0Management%20of%20Low-Flow,%20Low-Gradient%20Aortic%C2%A0Stenosis&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Annabi,%20Mohamed-Salah&rft.date=2018-02-06&rft.volume=71&rft.issue=5&rft.spage=475&rft.epage=485&rft.pages=475-485&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2017.11.052&rft_dat=%3Cproquest_cross%3E2007528462%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007528462&rft_id=info:pmid/29406851&rft_els_id=S0735109717417785&rfr_iscdi=true |